Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy Xianyong Zhou et al, 2023, Molecular Cancer CrossRef
The synergistic effect of mefenamic acid with ionizing radiation in colon cancer Seyed Jalal Hosseinimehr et al, 2019, Journal of Bioenergetics and Biomembranes CrossRef
Two isostructural Co(II) flufenamato and niflumato complexes with bathocuproine: Analogues with a different cytotoxic activity Lukáš Smolko et al, 2020, Journal of Inorganic Biochemistry CrossRef
Butein induces apoptotic cell death of human cervical cancer cells Pei‑Yu Yang et al, 2018, Oncology Letters CrossRef
Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types Medi Kori et al, 2022, Frontiers in Pharmacology CrossRef
Proteomics analysis of meclofenamic acid‐treated small cell lung carcinoma cells revealed changes in cellular energy metabolism for cancer cell survival Sevinc Yanar et al, 2023, Journal of Biochemical and Molecular Toxicology CrossRef
Niosomal formulation of mefenamic acid for enhanced cancer targeting; preparation, characterization and biodistribution study using radiolabeling technique Mona A. Shewaiter et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
Synergistic effect of a nonsteroidal anti-inflammatory drug in combination with topotecan on small cell lung cancer cells Sevinc Yanar et al, 2024, Molecular Biology Reports CrossRef
Potential drug targets against HPV and repurposing of existing drugs Utkarsha Sahu et al, 2022, Immunopathology, Diagnosis and Treatment of HPV Induced Malignancies CrossRef
The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells Aline Kowalski-Chauvel et al, 2020, Cancers CrossRef
Different effects of the nonsteroidal anti-inflammatory drugs meclofenamate sodium and naproxen sodium on proteasome activity in cardiac cells Rajeshwary Ghosh et al, 2016, Journal of Molecular and Cellular Cardiology CrossRef
Meclofenamic acid inhibits the invasion and migration of LNCaP prostate carcinoma cells by regulating vimentin expression Aylin KANLI et al, 2022, Acta Medica Nicomedia CrossRef
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification Bowen Li et al, 2020, Drug Resistance Updates CrossRef
Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis Biqing Chen et al, 2023, Archives of Biochemistry and Biophysics CrossRef
Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid
Zhuo-Yue Li et al, 2020, International Journal of Nanomedicine CrossRef
Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity Azza El-Sheikh et al, 2021, Medicina CrossRef
Hollow Magnetic Iron Oxide Nanoparticles as Sodium Meclofenamate Drug Delivery Systems Méndez-Rojas Miguel A, 2016, Journal of Nanomedicine Research CrossRef
Antitumor Effects of Annopurpuricin A, an Acetogenin from the Roots of Annona purpurea Gustavo A. Hernández-Fuentes et al, 2023, Revista Brasileira de Farmacognosia CrossRef
Decreased biochemical progression in patients with castration‑resistant prostate cancer using a novel mefenamic acid anti‑inflammatory therapy: A randomized controlled trial Jos� Guzman‑Esquivel et al, 2020, Oncology Letters CrossRef
Mechanistic Insight for Targeting Biomolecules by Ruthenium(II) NSAID Complexes Chanchal Sonkar et al, 2020, ACS Applied Bio Materials CrossRef
The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics Janice García-Quiroz et al, 2022, Cells CrossRef